Daniel Roberts focuses his practice on intellectual property with an emphasis on life sciences patent litigation. He has argued before the U.S. Court of Appeals for the Federal Circuit and the U.S. District Court for the District of Delaware.

He was previously a research chemist in the pharmaceutical industry for nearly a decade, specializing in drug product design, high-throughput crystallization, small molecule and protein crystallography, and tech transfer. His research areas were virology, metabolic disorders, cardiovascular disorders and oncology, particularly PD1/PDL1. He is a named inventor on numerous patents and patent applications, including U.S. Patent No. 8,759,372 (Roberts et al.) directed to a crystal form of a CGRP antagonist. His writing has appeared in Reuters, JD Supra, NYIPLA: The Report, Law360 and Crystal Growth & Design.

Mr. Roberts maintains an active pro bono practice, working with veterans to secure government benefits in the Court of Appeals for Veterans’ Claims and the U.S. Court of Appeals for the Federal Circuit, as well as assisting victims of battery or extreme cruelty in obtaining lawful permanent residence in the U.S.